Professional Advisory Services’s AstraZeneca AZN Stock Holding History

Professional Advisory Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$29.7M	Buy	181,963 +20,339	+13%	+$3.39M	3.55%	6
2026 Q2	$30.2M	Buy	+161,624	New	+$30.4M	3.62%	7
2026 Q1	–	Sell	-152,949	Closed	-$28.1M	–	81
2025 Q4	$28.1M	Sell	152,949 -11,372	-7%	-$1.99M	3.64%	7
2025 Q3	$25.2M	Buy	164,321 +798	+0.5%	+$121K	3.28%	8
2025 Q2	$22.9M	Buy	163,523 +10,806	+7%	+$1.51M	3.1%	9
2025 Q1	$22.4M	Sell	152,717 -13,756	-8%	-$1.99M	3.14%	12
2024 Q4	$21.8M	Buy	166,473 +28,209	+20%	+$3.95M	3.01%	12
2024 Q3	$21.5M	Sell	138,264 -1,850	-1%	-$299K	2.83%	21
2024 Q2	$21.9M	Sell	140,114 -8,770	-6%	-$1.32M	2.98%	12
2024 Q1	$20.2M	Buy	+148,884	New	+$19.7M	2.74%	24

Other funds holding AZN

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Oslo Pensjonsforsikring Oslo $863M AUM 18.29% 1-Year Est. Return

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Professional Advisory Services's AZN Position: Q3 2026 in Review

Professional Advisory Services increased its AstraZeneca (AZN) stake by 13% in Q3 2026, buying an estimated $3.39M and bringing the position to 181,963 shares worth $29.7M. The position accounts for 3.55% of the portfolio, ranked #6.

Professional Advisory Services first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. The position peaked at $30.2M in Q2 2026. 239 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Professional Advisory Services held 181,963 shares of AstraZeneca worth $29.7M as of Q3 2026.
Professional Advisory Services bought 20,339 AstraZeneca shares in Q3 2026, an estimated $3.39M.
AstraZeneca made up 3.55% of Professional Advisory Services's portfolio in Q3 2026, its #6 holding.
Professional Advisory Services first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
Professional Advisory Services's AstraZeneca position peaked at $30.2M in Q2 2026.
239 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Professional Advisory Services's 13F filing for Q3 2026, filed 8 Oct 2026.